Page last updated: 2024-09-05

muraglitazar and exenatide

muraglitazar has been researched along with exenatide in 1 studies

Compound Research Comparison

Studies (muraglitazar)	Trials (muraglitazar)	Recent Studies (post-2010) (muraglitazar)	Studies (exenatide)	Trials (exenatide)	Recent Studies (post-2010) (exenatide)
85	10	25	2,806	383	2,016

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lebovitz, H	1

Reviews

1 review(s) available for muraglitazar and exenatide

Article	Year
Diabetes: assessing the pipeline. Atherosclerosis. Supplements, 2006, Volume: 7, Issue:1 Topics: Adamantane; Alkanesulfonates; Amyloid; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Exenatide; Glycine; Humans; Hypoglycemic Agents; Indoles; Islet Amyloid Polypeptide; Maleimides; Nitriles; Oxazoles; Peptides; Phenylpropionates; Piperidines; PPAR alpha; PPAR gamma; Protein Kinase C; Pyrazoles; Pyrrolidines; Receptor, Cannabinoid, CB1; Receptors, Glucagon; Rimonabant; Venoms; Vildagliptin	2006

Article

Year

Diabetes: assessing the pipeline.

Atherosclerosis. Supplements, 2006, Volume: 7, Issue:1

Topics: Adamantane; Alkanesulfonates; Amyloid; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Exenatide; Glycine; Humans; Hypoglycemic Agents; Indoles; Islet Amyloid Polypeptide; Maleimides; Nitriles; Oxazoles; Peptides; Phenylpropionates; Piperidines; PPAR alpha; PPAR gamma; Protein Kinase C; Pyrazoles; Pyrrolidines; Receptor, Cannabinoid, CB1; Receptors, Glucagon; Rimonabant; Venoms; Vildagliptin

2006